Rudi, W.-S.; Molitor, M.; Garlapati, V.; Finger, S.; Wild, J.; Münzel, T.; Karbach, S.H.; Wenzel, P.
ACE Inhibition Modulates Myeloid Hematopoiesis after Acute Myocardial Infarction and Reduces Cardiac and Vascular Inflammation in Ischemic Heart Failure. Antioxidants 2021, 10, 396.
https://doi.org/10.3390/antiox10030396
AMA Style
Rudi W-S, Molitor M, Garlapati V, Finger S, Wild J, Münzel T, Karbach SH, Wenzel P.
ACE Inhibition Modulates Myeloid Hematopoiesis after Acute Myocardial Infarction and Reduces Cardiac and Vascular Inflammation in Ischemic Heart Failure. Antioxidants. 2021; 10(3):396.
https://doi.org/10.3390/antiox10030396
Chicago/Turabian Style
Rudi, Wolf-Stephan, Michael Molitor, Venkata Garlapati, Stefanie Finger, Johannes Wild, Thomas Münzel, Susanne H. Karbach, and Philip Wenzel.
2021. "ACE Inhibition Modulates Myeloid Hematopoiesis after Acute Myocardial Infarction and Reduces Cardiac and Vascular Inflammation in Ischemic Heart Failure" Antioxidants 10, no. 3: 396.
https://doi.org/10.3390/antiox10030396
APA Style
Rudi, W.-S., Molitor, M., Garlapati, V., Finger, S., Wild, J., Münzel, T., Karbach, S. H., & Wenzel, P.
(2021). ACE Inhibition Modulates Myeloid Hematopoiesis after Acute Myocardial Infarction and Reduces Cardiac and Vascular Inflammation in Ischemic Heart Failure. Antioxidants, 10(3), 396.
https://doi.org/10.3390/antiox10030396